Neurogenetic Testing Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: NDB684813270EN
Market Monitor Global

Abstracts

Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.

This report contains market size and forecasts of Neurogenetic Testing in Global, including the following market information:

Global Neurogenetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Neurogenetic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

MRI Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neurogenetic Testing include Labcorp, Pacific Biosciences of California, Victorian Clinical Genetics Services, MedGenome Labs, Blueprint Genetics, GeneDx, Mayo Clinic and Neurogene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurogenetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neurogenetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Neurogenetic Testing Market Segment Percentages, by Type, 2021 (%)

• MRI
• Next Generation Sequencing
• Multiplex Ligation-dependent Probe Amplification (MLPA)
• Fragment Analysis PCR

Global Neurogenetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Neurogenetic Testing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Research Institutes
• Diagnostics Laboratories

Global Neurogenetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Neurogenetic Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neurogenetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Neurogenetic Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Labcorp
• Pacific Biosciences of California
• Victorian Clinical Genetics Services
• MedGenome Labs
• Blueprint Genetics
• GeneDx
• Mayo Clinic
• Neurogene

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neurogenetic Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neurogenetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROGENETIC TESTING OVERALL MARKET SIZE

2.1 Global Neurogenetic Testing Market Size: 2021 VS 2028
2.2 Global Neurogenetic Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neurogenetic Testing Players in Global Market
3.2 Top Global Neurogenetic Testing Companies Ranked by Revenue
3.3 Global Neurogenetic Testing Revenue by Companies
3.4 Top 3 and Top 5 Neurogenetic Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neurogenetic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurogenetic Testing Players in Global Market
  3.6.1 List of Global Tier 1 Neurogenetic Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neurogenetic Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Neurogenetic Testing Market Size Markets, 2021 & 2028
  4.1.2 MRI
  4.1.3 Next Generation Sequencing
  4.1.4 Multiplex Ligation-dependent Probe Amplification (MLPA)
  4.1.5 Fragment Analysis PCR
4.2 By Type - Global Neurogenetic Testing Revenue & Forecasts
  4.2.1 By Type - Global Neurogenetic Testing Revenue, 2017-2022
  4.2.2 By Type - Global Neurogenetic Testing Revenue, 2023-2028
  4.2.3 By Type - Global Neurogenetic Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neurogenetic Testing Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Research Institutes
  5.1.5 Diagnostics Laboratories
5.2 By Application - Global Neurogenetic Testing Revenue & Forecasts
  5.2.1 By Application - Global Neurogenetic Testing Revenue, 2017-2022
  5.2.2 By Application - Global Neurogenetic Testing Revenue, 2023-2028
  5.2.3 By Application - Global Neurogenetic Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neurogenetic Testing Market Size, 2021 & 2028
6.2 By Region - Global Neurogenetic Testing Revenue & Forecasts
  6.2.1 By Region - Global Neurogenetic Testing Revenue, 2017-2022
  6.2.2 By Region - Global Neurogenetic Testing Revenue, 2023-2028
  6.2.3 By Region - Global Neurogenetic Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Neurogenetic Testing Revenue, 2017-2028
  6.3.2 US Neurogenetic Testing Market Size, 2017-2028
  6.3.3 Canada Neurogenetic Testing Market Size, 2017-2028
  6.3.4 Mexico Neurogenetic Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Neurogenetic Testing Revenue, 2017-2028
  6.4.2 Germany Neurogenetic Testing Market Size, 2017-2028
  6.4.3 France Neurogenetic Testing Market Size, 2017-2028
  6.4.4 U.K. Neurogenetic Testing Market Size, 2017-2028
  6.4.5 Italy Neurogenetic Testing Market Size, 2017-2028
  6.4.6 Russia Neurogenetic Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Neurogenetic Testing Market Size, 2017-2028
  6.4.8 Benelux Neurogenetic Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Neurogenetic Testing Revenue, 2017-2028
  6.5.2 China Neurogenetic Testing Market Size, 2017-2028
  6.5.3 Japan Neurogenetic Testing Market Size, 2017-2028
  6.5.4 South Korea Neurogenetic Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Neurogenetic Testing Market Size, 2017-2028
  6.5.6 India Neurogenetic Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Neurogenetic Testing Revenue, 2017-2028
  6.6.2 Brazil Neurogenetic Testing Market Size, 2017-2028
  6.6.3 Argentina Neurogenetic Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neurogenetic Testing Revenue, 2017-2028
  6.7.2 Turkey Neurogenetic Testing Market Size, 2017-2028
  6.7.3 Israel Neurogenetic Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Neurogenetic Testing Market Size, 2017-2028
  6.7.5 UAE Neurogenetic Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Labcorp
  7.1.1 Labcorp Corporate Summary
  7.1.2 Labcorp Business Overview
  7.1.3 Labcorp Neurogenetic Testing Major Product Offerings
  7.1.4 Labcorp Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.1.5 Labcorp Key News
7.2 Pacific Biosciences of California
  7.2.1 Pacific Biosciences of California Corporate Summary
  7.2.2 Pacific Biosciences of California Business Overview
  7.2.3 Pacific Biosciences of California Neurogenetic Testing Major Product Offerings
  7.2.4 Pacific Biosciences of California Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.2.5 Pacific Biosciences of California Key News
7.3 Victorian Clinical Genetics Services
  7.3.1 Victorian Clinical Genetics Services Corporate Summary
  7.3.2 Victorian Clinical Genetics Services Business Overview
  7.3.3 Victorian Clinical Genetics Services Neurogenetic Testing Major Product Offerings
  7.3.4 Victorian Clinical Genetics Services Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.3.5 Victorian Clinical Genetics Services Key News
7.4 MedGenome Labs
  7.4.1 MedGenome Labs Corporate Summary
  7.4.2 MedGenome Labs Business Overview
  7.4.3 MedGenome Labs Neurogenetic Testing Major Product Offerings
  7.4.4 MedGenome Labs Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.4.5 MedGenome Labs Key News
7.5 Blueprint Genetics
  7.5.1 Blueprint Genetics Corporate Summary
  7.5.2 Blueprint Genetics Business Overview
  7.5.3 Blueprint Genetics Neurogenetic Testing Major Product Offerings
  7.5.4 Blueprint Genetics Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.5.5 Blueprint Genetics Key News
7.6 GeneDx
  7.6.1 GeneDx Corporate Summary
  7.6.2 GeneDx Business Overview
  7.6.3 GeneDx Neurogenetic Testing Major Product Offerings
  7.6.4 GeneDx Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.6.5 GeneDx Key News
7.7 Mayo Clinic
  7.7.1 Mayo Clinic Corporate Summary
  7.7.2 Mayo Clinic Business Overview
  7.7.3 Mayo Clinic Neurogenetic Testing Major Product Offerings
  7.7.4 Mayo Clinic Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.7.5 Mayo Clinic Key News
7.8 Neurogene
  7.8.1 Neurogene Corporate Summary
  7.8.2 Neurogene Business Overview
  7.8.3 Neurogene Neurogenetic Testing Major Product Offerings
  7.8.4 Neurogene Neurogenetic Testing Revenue in Global Market (2017-2022)
  7.8.5 Neurogene Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Neurogenetic Testing Market Opportunities & Trends in Global Market
Table 2. Neurogenetic Testing Market Drivers in Global Market
Table 3. Neurogenetic Testing Market Restraints in Global Market
Table 4. Key Players of Neurogenetic Testing in Global Market
Table 5. Top Neurogenetic Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neurogenetic Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neurogenetic Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neurogenetic Testing Product Type
Table 9. List of Global Tier 1 Neurogenetic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurogenetic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neurogenetic Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neurogenetic Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neurogenetic Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Neurogenetic Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neurogenetic Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neurogenetic Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Neurogenetic Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neurogenetic Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neurogenetic Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neurogenetic Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neurogenetic Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neurogenetic Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neurogenetic Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neurogenetic Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neurogenetic Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neurogenetic Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neurogenetic Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neurogenetic Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neurogenetic Testing Revenue, (US$, Mn), 2023-2028
Table 30. Labcorp Corporate Summary
Table 31. Labcorp Neurogenetic Testing Product Offerings
Table 32. Labcorp Neurogenetic Testing Revenue (US$, Mn), (2017-2022)
Table 33. Pacific Biosciences of California Corporate Summary
Table 34. Pacific Biosciences of California Neurogenetic Testing Product Offerings
Table 35. Pacific Biosciences of California Neurogenetic Testing Revenue (US$, Mn), (2017-2022)
Table 36. Victorian Clinical Genetics Services Corporate Summary
Table 37. Victorian Clinical Genetics Services Neurogenetic Testing Product Offerings
Table 38. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (US$, Mn), (2017-2022)
Table 39. MedGenome Labs Corporate Summary
Table 40. MedGenome Labs Neurogenetic Testing Product Offerings
Table 41. MedGenome Labs Neurogenetic Testing Revenue (US$, Mn), (2017-2022)
Table 42. Blueprint Genetics Corporate Summary
Table 43. Blueprint Genetics Neurogenetic Testing Product Offerings
Table 44. Blueprint Genetics Neurogenetic Testing Revenue (US$, Mn), (2017-2022)
Table 45. GeneDx Corporate Summary
Table 46. GeneDx Neurogenetic Testing Product Offerings
Table 47. GeneDx Neurogenetic Testing Revenue (US$, Mn), (2017-2022)
Table 48. Mayo Clinic Corporate Summary
Table 49. Mayo Clinic Neurogenetic Testing Product Offerings
Table 50. Mayo Clinic Neurogenetic Testing Revenue (US$, Mn), (2017-2022)
Table 51. Neurogene Corporate Summary
Table 52. Neurogene Neurogenetic Testing Product Offerings
Table 53. Neurogene Neurogenetic Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Neurogenetic Testing Segment by Type in 2021
Figure 2. Neurogenetic Testing Segment by Application in 2021
Figure 3. Global Neurogenetic Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neurogenetic Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neurogenetic Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurogenetic Testing Revenue in 2021
Figure 8. By Type - Global Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 12. US Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 16. Germany Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 24. China Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neurogenetic Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neurogenetic Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Labcorp Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pacific Biosciences of California Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Victorian Clinical Genetics Services Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. MedGenome Labs Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Blueprint Genetics Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GeneDx Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mayo Clinic Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Neurogene Neurogenetic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)